Brief: Cumberland Pharmaceuticals Reports 41% Revenue Growth
08/11/2022 23:28
Nov 8 (Reuters) - Cumberland Pharmaceuticals Inc
CPIX.O :
* CUMBERLAND PHARMACEUTICALS INC QUARTERLY REVENUE ROSE 41
PERCENT
TO $11.4 MILLION
* CUMBERLAND PHARMACEUTICALS REPORTS 41% REVENUE GROWTH
* CUMBERLAND PHARMACEUTICALS INC Q3 ADJUSTED EARNINGS PER
SHARE
$0.10
* CUMBERLAND PHARMACEUTICALS INC QTRLY LOSS PER SHARE $0.03
Source text for Eikon: ID:nPn2lRR9Qa
Further company coverage: CPIX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cumberland Pharmaceuticals
See all newsBrief: Cumberland Pharmaceuticals Announces Assist-Ssc Trial Top-Line Results
Cumberland Pharmaceuticals Q2 loss widens after Apotex transaction
Brief: Cumberland Pharmaceuticals Announces Special Dividend Of $1.50 Per Share
Cumberland Pharmaceuticals Q1 revenue up 5%; to sell FDA‑approved brands to Apotex for $100 mln
NASDAQ RESUMED AT 09:38 AM